CXCL10 and CCL2 chemokine serum levels in patients with hepatitis c associated with autoimmune thyroiditis

Journal of Interferon and Cytokine Research

Volumn 29, Issue 6, 2009, Pages 345-351

  Antonelli, Alessandro ^a   Ferri, Clodoveo ^b   Fallahi, Poupak ^a   Ferrari, Silvia Martina ^a   Frascerra, Silvia ^a   Pampana, Alessandro ^a   Panicucci, Erica ^a   Carpi, Angelo ^a   Nicolini, Andrea ^a   Ferrannini, Ele ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANALYSIS OF VARIANCE; ARTICLE; ASPIRATION BIOPSY; AUTOIMMUNE THYROIDITIS; BLOOD FLOW; CHI SQUARE TEST; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENOTYPE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEROLOGY; TH1 CELL; THYROTROPIN BLOOD LEVEL; VIROLOGY;

AGED; ANTIGENS, VIRAL; BIOPSY; CHEMOKINE CCL2; CHEMOKINE CXCL10; CHEMOKINES; FEMALE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; SEROLOGIC TESTS; THYROIDITIS, AUTOIMMUNE; VIRULENCE;

HEPATITIS C VIRUS;

EID: 66149183133     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2008.0090     Document Type: Article

References (35)

1. Antonelli A, Ferri C, Fallahi P. 1999. Thyroid cancer in patients with hepatitis C infection. JAMA 281:1588.
2. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Buonamano A, Ferrannini E, Serio M. 2004. High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab 89:5496-5499.
3. Antonelli A, Ferri C, Fallahi P, Sebastiani M, Nesti C, Barani L, Barale R, Ferrannini E. 2004a. Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. Rheumatology (Oxford) 43:238-240.
4. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Paolicchi A, Ferrannini E, Serio M. 2005. Increase of inter-feron-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. Eur J Endocrinol 152:171-177.
5. Antonelli A, Rotondi M, Ferrari SM, Fallahi P, Romagnani P, Franceschini SS, Serio M, Ferrannini E. 2006. Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' oph-thalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. J Clin Endocrinol Metab 91:614-620.
6. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Barani L, Ferrannini E, Serio M. 2006a. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. Clin Endocrinol (Oxf) 64:189-195.
7. Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Romagnani P, Grosso M, Ferrannini E, Serio M. 2006b. Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specif cally sustained by the autoimmune, inf ammatory process. Eur J Endocrinol 154:651-658.
8. Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Serio M, Miccoli P. 2006c. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy. Br J Surg 93:1226-1231.
9. Antonelli A, Rotondi M, Fallahi P, Ferrari SM, Paolicchi A, Romagnani P, Serio M, Ferrannini E. 2006d. Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing. Cytokine 34:32-38.
10. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Ghinoi A, Rotondi M, Ferrannini E. 2006e. Thyroid disorders in chronic hepatitis C virus infection. Thyroid 16:563-572.
11. Antonelli A, Rotondi M, Fallahi P, Grosso M, Boni G, Ferrari SM, Romagnani P, Serio M, Mariani G, Ferrannini E. 2007. Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiter. J Clin Endocrinol Metab 92:1485-1490.
12. Apolinario A, Majano PL, Lorente R, Núñez O, Clemente G, García-Monzón C. 2005. Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins. J Viral Hepat 12:27-37.
13. Bièche I, Asselah T, Laurendeau I, Vidaud D, Degot C, Paradis V, Bedossa P, Valla DC, Marcellin P, Vidaud M. 2005. Molecular prof ling of early stage liver f brosis in patients with chronic hepatitis C virus infection. Virology 332:130-144.
14. Butera D, Marukian S, Iwamaye AE, Hembrador E, Chambers TJ, Di Bisceglie AM, Charles ED, Talal AH, Jacobson IM, Rice CM, Dustin LB. 2005. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood 106:1175 -1182.
15. Diago M, Castellano G, García-Samaniego J, Pérez C, Fernández I, Romero M, Iacono OL, García-Monzón C. 2006. Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut 55:374-379.
16. Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, Gentilini P, Bombardieri S, Zignego AL. 1993. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 82:3701-3704.
17. Ferri C, Zignego AL. 2000. Relation between infection and auto-immunity in mixed cryoglobulinemia. Curr Opin Rheumatol 12:53-60.
18. García-López MA, Sancho D, Sánchez-Madrid F, Marazuela M. 2001. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes. J Clin Endocrinol Metab 86:5008-5016.
19. Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, Engels EA. 2007. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 297: 2010-2017.
20. Harvey CE, Post JJ, Palladinetti P, Freeman AJ, Ffrench RA, Kumar RK, Marinos G, Lloyd AR. 2003. Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inf ammation. J Leukoc Biol 74:360-369.
21. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, Phillipsk MJ, Portmannl BG, Poulsenm H, Scheuer PJ, Schmidn M, Thalero H. 1995. Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699.
22. Itoh Y, Morita A, Nishioji K, Narumi S, Toyama T, Daimon Y, Nakamura H, Kirishima T, Okanoue T. 2001. Clinical signifcance of elevated serum interferon- inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels. J Viral Hepat 8:341-348.
23. Karpus WJ, Lukacs NW, Kennedy KJ, Smith WS, Hurst SD, Barrett TA. 1997. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 158:4129-4136.
24. Kemp EH, Metcalfe RA, Smith KA, Woodroofe MN, Watson PF, Weetman A P. 2003. Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clin Endocrinol (Oxf) 59:207-213.
25. Lagging M, Romero AI, Westin J, Norkrans G, Dhillon A P, Pawlotsky JM, Zeuzem S, von Wagner M, Negro F, Schalm SW, Haagmans BL, Ferrari C, Missale G, Neuman n AU, Verheij-Hart E, Hellstrand K; DITTO-HCV Study Group. 2006. IP-10 predicts viral response and therapeutic outcome in diff cult-to-treat patients with HCV genotype 1 infection. Hepatology 44:1617-1625.
26. Mangia A, Schiavone G, Lezzi G, Marmo R, Bruno F, Villani MR, Cascavilla I, Fantasia L, Andriulli A. 1998. HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol 93:2363-2367.
27. Mihm S, Schweyer S, Ramadori G. 2003. Expression of the chemokins IP-10 correlates with the accumulation of hepatic IFN-gamma and IL-18 mRNA in chronic hepatitis C but not in hepatitis B. J Med Virol 70:562-570.
28. Narumi S, Tominaga Y, Tamaru M, Shimai S, Okumura H, Nishioji K, Itoh Y, Okanoue T. 1997. Expression of IFN-inducible protein-10 in chronic hepatitis. J Immunol 158:5536-5544.
29. Nishioji K, Okanoue T, Itoh Y, Narumi S, Sakamoto M, Nakamura H, Morita A, Kashima K. 2001. Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes. Clin Exp Immunol 123:271-279.
30. Panasiuk A, Prokopowicz D, Panasiuk B. 2004. Monocyte chemo-tactic protein-1 and soluble adhesion molecules as possible prognostic markers of the eff cacy of antiviral treatment in chronic hepatitis C. World J Gastroenterol 10:3639-3642.
31. Prummel MF, Laurberg P. 2003. Interferon-alpha and autoimmune thyroid disease. Thyroid 13:547-551.
32. Romagnani P, Rotondi M, Lazzeri E, Lasagni L, Francalanci M, Buonamano A, Milani S, Vitti P, Chiovato L, Tonacchera M, Bellastella A, Serio M. 2002. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease. Am J Pathol 161:195-206.
33. Romero AI, Lagging M, Westin J, Dhillon A P, Dustin LB, Pawlotsky JM, Neumann AU, Ferrari C, Missale G, Haagmans BL, Schalm SW, Zeuzem S, Negro F, Verheij-Hart E, Hellstrand K; DITTO -HCV Study Group. 2006. Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. J Infect Dis 194:895-903.
34. Rotondi M, Rosati A, Buonamano A, Lasagni L, Lazzeri E, Pradella F, Fossombroni V, Cirami C, Liotta F, La Villa G, Serio M, Bertoni E, Salvadori M, Romagnani P. 2004. High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. Am J Transplant 4:1466-1474.
35. Zlotnik A, Yoshie O. 2000. Chemokines: a new classif cation system and their role in immunity. Immunity 12:121-127.